The effects of curcumin on Attention-Deficit/Hyperactivity Disorder (ADHD) patients
Phase 2
Recruiting
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD).Disturbance of activity and attention
- Registration Number
- IRCT2017050433810N1
- Lead Sponsor
- Vice Chancellor for Research, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Aged between 7 and 15 years; diagnosis Attention-Deficit/Hyperactivity Disorder (ADHD) based on DSM-V-TR criteria; lack of mental retardation (MR), epilepsy, pervasive developmental disorder, schizophrenia, mania episode, anxiety disorders, bipolar disorder, special ability and learning disorders, and hyperactivity disorder due to organic brain syndrome (OBS) or drug reactions.
Exclusion criteria: Liver and renal failure; thyroid disorder; allergy to curcumin; chronic inflammatory diseases; use of anti-inflammatory and antioxidant drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation the effectiveness of clinical outcomes including learn, impulsivity, anxiety, hyperactivity and conduct disorder (CD) score. Timepoint: before, 4 and 8 weeks after intervention. Method of measurement: Base on questionnaire.
- Secondary Outcome Measures
Name Time Method